what is bit currency People searches

Iran's Supreme Leader Ayatollah Ali Khamenei vowed to expand Iran's axis of resistance in the Middle East.The interest rate of active bonds of 10-year and 30-year treasury bonds went down by more than 2bp, and the yield of main inter-bank interest bonds went down. The interest rate of 10-year treasury bonds went down by 2.15bp to 1.82%. The interest rate of 30-year national debt 2400006 fell by 2.15bp to 2.3075%; In 10 years, the interest rate of CDB 240215 dropped by 2.65bp to 1.886%.On the 11th, soybean oil rose by 1.72%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract soybean oil closed at 2,505, up or down by +1.72%, with a turnover of 529,500 lots. The position data showed that the top 20 seats were clear, and the difference position was 59,880 lots. The total contract turnover of soybean oil futures was 685,800 lots, a decrease of 114,300 lots from the previous day. The first 20 seats in the contract held 687,800 lots, an increase of 15,900 lots over the previous day. The short positions in the top 20 seats of the contract were 775,600 lots, an increase of 3,312 lots over the previous day. (Sina Futures)

The Israeli army has launched more than 350 attacks in Syria. According to the news of Syrian Human Rights Watch on December 11th, local time, up to now, Israel has launched more than 352 attacks in Syria, destroying military facilities in 13 provinces in Syria. On the 10th local time, the Israel Defense Forces issued a statement saying that up to now, the Israeli military has cracked down on 320 strategic targets in Syria and destroyed weapons that may fall into the hands of hostile forces. According to Israeli military estimates, more than 70% of Syria's military forces have been destroyed.As of the close of early trading, the Nikkei 225 index fell by 0.65% and the Dongzheng index fell by 0.2%.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.

As of the close of early trading, the Nikkei 225 index fell by 0.65% and the Dongzheng index fell by 0.2%.Grant Thornton Group, a Hong Kong financial consulting and IPO sponsor service provider, is priced at $ 4-5 per share, and plans to raise $10 million.Hualu Hengsheng: The adipic acid plant of nylon 66 high-end new material project was put into production. Hualu Hengsheng (600426) announced on the evening of December 11th that the adipic acid plant of the company's nylon 66 high-end new material project had been put through the process, produced qualified products and entered the trial production stage. Production facilities such as nylon 66 are currently under construction. After the adipic acid plant is put into production, 200,000 tons/year of adipic acid can be added, which lays a foundation for the company to further expand the new chemical materials sector and is conducive to improving the comprehensive competitiveness of enterprises.